tiprankstipranks
Nurix Therapeutics (NRIX)
NASDAQ:NRIX
US Market
NRIX
Nurix Therapeutics
RESEARCH TOOLSreports
Want to see NRIX full AI Analyst Report?

Nurix Therapeutics (NRIX) Income Statement

574 Followers

Nurix Therapeutics Income Statement

Last quarter (Q1 2026), Nurix Therapeutics's total revenue was $6.25M, a decrease of -66.12% from the same quarter last year. In Q1, Nurix Therapeutics's net income was $-87.17M. See Nurix Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Nov 25Nov 24Nov 23Nov 22Nov 21
Total Revenue
$ 83.98M$ 54.55M$ 76.99M$ 38.63M$ 29.75M
Gross Profit
$ 65.12M$ -167.08M$ -112.16M$ -145.87M$ -86.68M
Operating Expenses
$ 350.79M$ 45.94M$ 42.90M$ 38.00M$ 31.20M
Depreciation and Amortization
$ 18.86M$ 8.02M$ 6.13M$ 4.15M$ 1.99M
EBITDA
$ -244.84M$ -205.01M$ -148.93M$ -179.72M$ -115.90M
Operating Income
$ -285.67M$ -213.03M$ -155.06M$ -183.87M$ -117.89M
Other Income/Expenses
$ 21.97M$ 19.73M$ 11.12M$ 3.51M$ 823.00K
Pretax Income
$ -263.70M$ -193.30M$ -143.95M$ -180.36M$ -117.06M
Net Income
$ -264.46M$ -193.57M$ -143.95M$ -180.36M$ -117.19M
Per Share Metrics
Basic EPS
$ -3.05$ -2.88$ -2.65$ -3.71$ -2.73
Diluted EPS
$ -3.05$ -2.88$ -2.65$ -3.71$ -2.73
Weighted Average Shares Outstanding
 86.67M 67.12M 54.34M 48.61M 42.90M
Weighted Average Shares Outstanding (Diluted)
 86.67M 67.12M 54.34M 48.61M 42.90M
Currency in USD

Nurix Therapeutics Earnings and Revenue History